Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZLI for Exacerbations of Cystic Fibrosis (AZTEC-CF)
NCT02894684Phase 4Completed
- Sponsor
- Liverpool Heart and Chest Hospital
- Start
- Jan 2017
- Primary completion
- Feb 2019
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aztreonam in cystic fibrosis (CF), Pseudomonas aeruginosa infection, sponsored by Liverpool Heart and Chest Hospital. Started Jan 2017; status: completed.
02
Drugs
aztreonam
03
Conditions
cystic fibrosis (CF)Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT02894684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02894684.